Graviola Annona Muricata.
Graviola Annona Muricata supplementation for targeted health support. But neurotoxic compounds (annonacin) are also present. Traditional uses include parasites and fever.
Reviewed March 2026
- Category
- Plant extract
What Graviola Annona Muricata is, and what it does.
- Does it work
- Lab results don't translate to proven human therapy. Neurotoxicity risk is real. Not recommended.
- How much to take
- As occasional fruit: fine. As supplement: not recommended due to neurotoxicity concerns.
- Time to feel it
- Nobody has timed an onset in people. Leaf infusions have traditionally been drunk for a settling effect within the hour, though no controlled study has measured that.
- The first dose
- Day one is a bitter leaf tea or capsule with nothing measurable to report. Traditional accounts describe a settling effect within the hour, which no controlled study has tested.
- With regular use
- Unknown efficacy, possible neurological harm with regular use.
- How well tolerated
- This one needs care. Its acetogenins block mitochondrial complex I, and animal work flags nerve cell injury with sustained intake. Seed and root carry the most. Ask a clinician first.
- How it feels
- Fruit tastes good. Supplements provide nothing noticeable.
- The overlooked benefit
- The plant part on the label matters more than the milligrams. Seed and root bark carry far more acetogenins than leaf or fruit pulp, so a leaf-only extract is a different material.
500 to 1,000mg a day is where Graviola Annona Muricata works.
Source: Moghadamtousi et al. J Ethnopharmacol 2015; mostly in vitro/animal data
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Graviola Annona Muricata has emerging evidence. Based on 59+ studies.
- Kills cancer cells in labAcetogenins are cytotoxic in vitro
- Cures cancer in humansZero human clinical trials
- Neurotoxicity riskEpidemiological link to atypical Parkinsonism
Questions people ask about Graviola Annona Muricata.
- What's the neurotoxicity concern?
- Annonacin can cause atypical Parkinsonism. Observed in Caribbean populations with high soursop consumption.
- Is eating the fruit safe?
- Occasional consumption is likely fine. Regular high intake or concentrated supplements are concerning.
- Why do people promote it?
- Lab studies are exciting but don't prove human benefit. Marketing exploits hope without evidence.
- Any legitimate research?
- Yes, on acetogenins. But from lab to human treatment is a huge gap. Plus the toxicity issue.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Annonaceous acetogenins are well characterised inhibitors of mitochondrial complex I, the entry point CoQ10 receives electrons from. Pairing them puts one ingredient against the other on the same respiratory chain.
NAD+ precursors are taken so NADH can hand electrons to complex I, the exact site acetogenins act on. Raising the cofactor pool has little effect where its downstream step is dampened.
Berberine is itself a mild complex I inhibitor, which is how it raises the AMP to ATP ratio and activates AMPK. Stacking it with acetogenin-bearing annona material puts two agents on the same target rather than covering different ground.
NADH dehydrogenase accepts electrons at an FMN site built from riboflavin. Annonaceous acetogenins, the characteristic constituents of Annona muricata, are established inhibitors of that same complex at the ubiquinone-binding site. Anyone reasoning about this combination should understand it as two agents acting on one enzyme from different positions, and the interaction has not been measured in people.
The whole function of complex I is to regenerate NAD+ from NADH while pumping protons. Blocking it lets NADH accumulate and restricts NAD+ regeneration, which slows every NAD-dependent dehydrogenase upstream. That is textbook bioenergetics and it is the reason acetogenin-containing material is treated with caution.
NR is phosphorylated to NMN and then adenylylated to NAD+, a settled route. As with NMN, it addresses NAD pool size rather than the redox ratio set by mitochondrial electron flow. The row is here to make the distinction, not to recommend the combination.
Lipoamide performs the acyl transfer and reoxidation steps in both dehydrogenase complexes, which is fixed biochemistry. Those complexes are the enzymes most directly stalled when NAD+ regeneration slows. The relationship is mechanistic and belongs in an explanation of mitochondrial metabolism rather than in a benefit claim.
Carnitine acetyltransferase converts excess acetyl-CoA to acetylcarnitine, which relieves acetyl-CoA build-up when the cycle backs up. This is established mitochondrial biochemistry. It describes normal energy metabolism and nothing here has been tested alongside this plant extract.
The carnitine palmitoyltransferase shuttle is the committed step for fatty acid entry into mitochondria and is rate-limiting for beta-oxidation. Beta-oxidation feeds NADH and FADH2 into the same electron transport chain. The connection is pathway-level and mechanistic.
Creatine kinase regenerates ATP from phosphocreatine and ADP without needing the electron transport chain. That makes it a cytosolic energy buffer operating on a different route from mitochondrial ATP synthesis. Settled biochemistry, and there is no study of the pair.
Taurine conjugation of mitochondrial tRNA uridine residues is required for accurate decoding of certain codons in mitochondrially encoded proteins, several of which are complex I subunits. The mechanism is well characterised in molecular work. Its relevance to a supplement pairing is theoretical.
Restricted electron flow through complex I increases electron leak and superoxide formation, and ascorbate is one of the species that scavenges the resulting radicals. It is also regenerated by glutathione, which links the two systems. The chemistry is established; a combined effect in people is not.
The mitochondrial glutathione pool is maintained separately from the cytosolic one and handles peroxides generated in the matrix. Any agent that increases electron leak raises demand on that pool. Standard redox biochemistry, offered as mechanism rather than as a claim.
Both contribute ortho-dihydroxy flavonoids that are conjugated by the same phase II enzymes after absorption. Sharing those enzymes means the two compete for conjugation capacity at higher combined doses. The direction is understood from flavonoid pharmacokinetics generally, not from work on this pair.
Animal work on Annona muricata extracts includes blood glucose measurements, and gymnemic acids have their own literature on the same measure. Stacking two ingredients that both point at glucose handling means the combined effect can exceed what either produces alone. This is a caution row: it flags additivity and does not claim a benefit.
Melatonin concentrates in the mitochondrial matrix and its oxidation products are themselves radical scavengers, a documented feature of the molecule. That places it in the same compartment where acetogenin activity would raise electron leak. Support is mechanistic and mostly from laboratory models.
Nothing specific on file for Graviola Annona Muricata. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Graviola Annona Muricata actually does.
Annona muricata produces annonaceous acetogenins, long-chain fatty acid derived compounds carrying tetrahydrofuran rings and a terminal lactone, which are the characteristic constituents of the genus.
Annonaceous acetogenins are potent inhibitors of mitochondrial complex I, acting at the ubiquinone binding site of NADH dehydrogenase.
Inhibiting complex I slows regeneration of NAD+ from NADH, which restricts flux through the NAD-dependent dehydrogenases of glycolysis and the citric acid cycle and lowers mitochondrial ATP output.
Annonacin is the most abundant acetogenin identified in Annona muricata fruit and seed, and it is lipophilic enough to cross biological membranes.
Where Graviola Annona Muricata comes from.
The tree's leaves or fruit are dried, then either brewed in water or soaked in alcohol to pull compounds out, and the liquid is concentrated into a powder or an oil. Which part of the plant went in matters more than anything else, because the seeds and roots carry far more of the compound that has drawn safety attention than the leaves or fruit do.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Leaves, fruit pulp, seed or root bark from a small tropical tree grown across the Americas, West Africa and Southeast Asia. Which part is used determines the chemistry more than any later step does.
Leaves are shade or air dried and milled; fruit pulp is separated from skin and seed and either frozen, pureed or dried.
Ethanol and water mixtures recover both phenolics and the lipophilic acetogenins. Water alone recovers mainly phenolics and alkaloids and leaves most acetogenin behind, so the solvent choice changes the product substantially.
Solvent is removed under reduced pressure to give a concentrated extract, usually described by a plant-to-extract ratio.
Dried onto a carrier for capsules and tablets, or held as an oil fraction. Marker-compound standardisation is uncommon in commercial supply.
Plant part, solvent and acetogenin content are almost never stated. Without the plant part, a consumer cannot tell whether a product is closer to a leaf tea or to a seed-derived concentrate, and those are chemically different materials.
Getting Graviola Annona Muricata from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Reviews the antioxidant constituents of graviola and concludes that its potential applications rest largely on laboratory and animal work, with human data limited.Narrative review. Olas, 2023 (Nutrients). PMID 36678273 ↗
- Reports that graviola oil extract was associated with changes in fattening performance and in circadian patterns of adipokine, cardiac and mitochondrial markers in the animals studied; these are measured markers, not clinical outcomes.Animal study. Kotan et al., 2026 (BMC Veterinary Research). PMID 41803858 ↗
- Reports that Annona muricata extract supplementation was associated with altered multi-organ energy metabolism markers in the animal model used.Animal study. Lee et al., 2023 (Nutrients). PMID 37299522 ↗
These are the studies our verdict leans on, chosen from the 3 we read for Graviola Annona Muricata. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.